FdaApplication
ANDA 213230
Identifiers
- fda_app_no: ANDA213230
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2022-01-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILODOSIN | SILODOSIN | 4MG | CAPSULE;ORAL |
| SILODOSIN | SILODOSIN | 8MG | CAPSULE;ORAL |
2 products